CIK 0000310158
- Large accelerated filer
Merck & Co., Inc.
Sign in to watch- Ticker
- MRK
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- Operating
- EIN
- 221918501
- Phone
- +1 908-740-4000
- Business address
- 126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
- Former names
- Merck & Co. Inc., SCHERING PLOUGH CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $8,611,875
- in 1 filing
Net −$8,611,875. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-04 | Zachary Jennifer EVP, General Counsel | Grant or award · Stock Option (Right to Buy) | +82,653 | 82,653 | ||
| 2021-05-04 | Zachary Jennifer EVP, General Counsel | Exercise or conversion · Restricted Stock Unit | −5,772 | 0 | ||
| 2021-05-04 | LeCointe-Cephas Lisa SVP Chief Ethics & Com Officer | Exercise or conversion | +694 | $75.98 | $53K | 2,612.35 |
| 2021-05-04 | LeCointe-Cephas Lisa SVP Chief Ethics & Com Officer | Shares withheld for taxes | −238 | $75.98 | $18K | 2,374.35 |
| 2021-05-04 | LeCointe-Cephas Lisa SVP Chief Ethics & Com Officer | Grant or award · Stock Option (Right to Buy) | +18,367 | 18,367 | ||
| 2021-05-04 | LeCointe-Cephas Lisa SVP Chief Ethics & Com Officer | Grant or award · Restricted Stock Unit | +2,369 | 2,369 | ||
| 2021-05-04 | LeCointe-Cephas Lisa SVP Chief Ethics & Com Officer | Exercise or conversion · Restricted Stock Unit | −694 | 0 | ||
| 2021-05-04 | DeLuca Richard R. EVP&Pres, Merck Animal Heallth | Grant or award · Stock Option (Right to Buy) | +82,653 | 82,653 | ||
| 2021-05-04 | Gerberding Julie L. EVP Strat Comm, GI Pub Policy | Grant or award · Stock Option (Right to Buy) | +39,796 | 39,796 | ||
| 2021-05-04 | Chattopadhyay Sanat Exe V-P & Pres. MMD | Grant or award · Stock Option (Right to Buy) | +85,714 | 85,714 | ||
| 2021-05-04 | Clyburn Frank EVP, Chief Commercial Officer | Exercise or conversion | +1,906 | $75.98 | $145K | 95,287.06 |
| 2021-05-04 | Clyburn Frank EVP, Chief Commercial Officer | Shares withheld for taxes | −939 | $75.98 | $71K | 94,348.06 |
| 2021-05-04 | Clyburn Frank EVP, Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +131,633 | 131,633 | ||
| 2021-05-04 | Clyburn Frank EVP, Chief Commercial Officer | Exercise or conversion · Restricted Stock Unit | −1,906 | 0 | ||
| 2021-05-04 | Davis Robert M President | Grant or award · Stock Option (Right to Buy) | +281,633 | 281,633 | ||
| 2021-05-04 | FRAZIER KENNETH C Chairman & CEO | Grant or award · Stock Option (Right to Buy) | +329,082 | 329,082 | ||
| 2021-05-03 | LeCointe-Cephas Lisa SVP Chief Ethics & Com Officer | Exercise or conversion | +437 | $74.50 | $33K | 2,068.35 |
| 2021-05-03 | LeCointe-Cephas Lisa SVP Chief Ethics & Com Officer | Shares withheld for taxes | −150 | $74.50 | $11K | 1,918.35 |
| 2021-05-03 | LeCointe-Cephas Lisa SVP Chief Ethics & Com Officer | Exercise or conversion · Restricted Stock Unit | −437 | 439 | ||
| 2021-05-03 | Litchfield Caroline EVP & CFO | Exercise or conversion | +750 | $74.50 | $56K | 19,544.12 |
Page 44 of 52 · 1,021 trades